BPC-157 vs GHRP-6
A comprehensive, data-driven comparison of BPC-157 (Body Protection Compound-157) and GHRP-6 (Growth Hormone Releasing Peptide-6). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | BPC-157 Body Protection Compound-157, PL 14736 | GHRP-6 Growth Hormone Releasing Peptide-6 |
|---|---|---|
| FDA Status | Category 2 (pending reclassification) | Not submitted |
| Category | Recovery & Healing | Growth Hormone |
| Primary Use | Tissue healing and injury recovery | Growth hormone optimization |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $50 - $120/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 250-500mcg daily | 100-300mcg 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth factors, and accelerates tissue repair | First-generation growth hormone secretagogue that stimulates GH release and increases appetite via ghrelin mimicry |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1GHRP-6 is generally more affordable ($35 - $70/mo) compared to BPC-157 ($50 - $120/mo).
- 2BPC-157 has low-quality evidence, while GHRP-6 has emerging-quality evidence.
- 3They belong to different categories: BPC-157 (Recovery & Healing) vs GHRP-6 (Growth Hormone).
Which Is Better For...
GHRP-6
More budget-friendly option with lower monthly costs
BPC-157
Fewer commonly reported side effects
BPC-157
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| BPC-157 | $50 - $120/mo | Category 2 (pending reclassification) | Various research labs |
| GHRP-6 | $35 - $70/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
BPC-157 works via Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth. GHRP-6 works via First-generation growth hormone secretagogue that stimulates GH release and increases appetite via. They differ in FDA approval status, efficacy data, and cost.
BPC-157 typically costs $50 - $120/mo, while GHRP-6 costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
BPC-157 is not FDA-approved (Category 2 (pending reclassification)). GHRP-6 is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of BPC-157 include Injection site discomfort, Mild headache, Dizziness. Common side effects of GHRP-6 include Significant increase in appetite, Water retention, Tingling or numbness. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
BPC-157 is a synthetic peptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. Although not FDA-approved, it has gained significant attention in research a...
View Full BPC-157 GuideGHRP-6 is a synthetic hexapeptide and one of the first growth hormone releasing peptides developed. It stimulates GH secretion by activating the ghrelin receptor. Unlike later-generation peptides like...
View Full GHRP-6 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between BPC-157 and GHRP-6 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.